world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
HEAD AND NECK CANCER<br />
SUMMARY<br />
> The most common <strong>cancer</strong> of the head<br />
and neck, namely oral <strong>cancer</strong>, ranks<br />
eleventh <strong>world</strong>wide (390,000 new cases<br />
per year), while <strong>cancer</strong>s of the pharynx<br />
(65,000 cases) and larynx (160,000<br />
cases) are less common.<br />
> Head and neck <strong>cancer</strong>s mainly afflict<br />
men, with sex ratios exceeding 10:1, and<br />
are typically caused by smoking, together<br />
with alcohol abuse. In some regions<br />
(e.g. India) oral <strong>cancer</strong> is mainly due to<br />
tobacco chewing. Multiple primary carcinomas<br />
are not uncommon.<br />
> Early-stage tumours can be surgically<br />
resected, but many patients are diagnosed<br />
with advanced disease and prognosis<br />
is poor. Oral <strong>cancer</strong> patients have<br />
a five-year survival rate of less than 50%.<br />
>Nasopharyngeal <strong>cancer</strong> is largely<br />
restricted to Southern Chinese populations<br />
and strongly associated with<br />
Epstein-Barr virus infection.<br />
Definition<br />
Head and neck <strong>cancer</strong>s as described here<br />
will be restricted to squamous cell carcinomas<br />
of the upper aerodigestive tract (which<br />
extends from the surface of the lips to the<br />
neck region of the oesophagus) and include<br />
the oral cavity, larynx and pharynx (comprising<br />
the oropharynx, hypopharynx and<br />
nasopharynx). Other tumours which occur in<br />
this area, such as those of the brain and thyroid<br />
and melanoma, are conventionally dealt<br />
with separately (Tumours of the nervous system,<br />
p265; Thyroid <strong>cancer</strong>, p257; Melanoma,<br />
p253).<br />
Epidemiology<br />
Cancers of the oral mucosa and oro- and<br />
hypopharynx can be considered together, as<br />
there are similarities in their epidemiology,<br />
treatment and prognosis. The geographic<br />
232 Human <strong>cancer</strong>s by organ site<br />
< 2.9<br />
< 4.6<br />
Fig. 5.88 The global incidence of oral <strong>cancer</strong> in men. Oral <strong>cancer</strong> is common in India, Australia, Hungary,<br />
France, Brazil and Southern Africa.<br />
patterns and trends in incidence for these<br />
<strong>cancer</strong>s vary depending upon the anatomical<br />
sub-sites concerned, a phenomenon that is<br />
often explicable by the influence of risk factors,<br />
such as tobacco use and alcohol consumption.<br />
A high incidence of these <strong>cancer</strong>s<br />
is observed in the Indian subcontinent,<br />
Australia, France, South America (Brazil) and<br />
Southern Africa (Fig. 5.88). Oral <strong>cancer</strong> is the<br />
11th most common <strong>cancer</strong> in the <strong>world</strong> in<br />
terms of number of cases, while <strong>cancer</strong> of<br />
the pharynx (apart from nasopharynx) ranks<br />
as 20th. Worldwide, about 389,000 new<br />
cases occurred in 2000, two-thirds of which<br />
were in developing countries, and these <strong>cancer</strong>s<br />
are responsible for some 200,000<br />
deaths each year.<br />
The male:female ratio of occurrence varies<br />
from 2-15:1 depending on the anatomical<br />
sub-site, with extreme ratios characteristic of<br />
tongue, floor of mouth and pharyngeal <strong>cancer</strong>s.<br />
The highest incidence among males is<br />
<strong>report</strong>ed in Bas-Rhin and Calvados in France,<br />
whereas among females the highest occurrence<br />
is observed in India. Cancers of the<br />
mouth and anterior two-thirds of the tongue<br />
< 6.2<br />
< 9.7<br />
Age-standardized incidence/100,000 population<br />
< 45.8<br />
generally predominate in developing countries,<br />
whereas pharyngeal <strong>cancer</strong>s are common<br />
in developed countries and in Central<br />
and Eastern Europe. In most countries,<br />
oral/pharyngeal <strong>cancer</strong> incidence and mortality<br />
rates have either been stable or increasing<br />
in the last four decades. Sharp increases<br />
in incidence have been <strong>report</strong>ed in Germany,<br />
Denmark, Scotland, Central and Eastern<br />
Europe, and there are increases in Japan,<br />
Australia and New Zealand, and in the USA<br />
among non-whites.<br />
New cases of <strong>cancer</strong> of the larynx occurring<br />
<strong>world</strong>wide number about 160,000, i.e. about<br />
2% of the total <strong>world</strong> <strong>cancer</strong> cases, making<br />
laryngeal <strong>cancer</strong> the 18thmost common <strong>cancer</strong>.<br />
The disease is markedly more frequent in<br />
males than in females (male:female ratio of<br />
12:1 and 6:1 in developing and developed<br />
countries respectively). There is a large geographic<br />
variability in disease frequency, highrisk<br />
countries being in Southern Europe<br />
(France, Italy, Spain), Eastern Europe (Russia,<br />
Ukraine), South America (Uruguay,<br />
Argentina), and Western Asia (Turkey, Iraq)<br />
(Fig. 5.89). Mortality from laryngeal <strong>cancer</strong> is